Accelerate the development of mRNA technologies through a coherent set of partnership projects.
Success of mRNA vaccines against COVID-19. Proof of concept studies of a large variety of applications. Promising ongoing clinical trials
Over the past decade, she has been particularly interested in mRNA-based vaccines and therapies and is developing innovative formulations for vaccination, cell therapy and protein replacement therapy.
Research projects and networks, financial support and collaborations.
In network with integrators and certified platforms in the territorry.
The talk about us. Check our last news.